Indian pharmaceutical firm Maan Pharmaceutical (Pvt) Ltd. has informed Sri Lanka’s Ministry of Health that it is willing to finance independent testing of the withdrawn batches of the Ondansetron injection at an internationally accredited laboratory.In a formal communication to the Ministry, the company requested that the relevant batches be sent for overseas analysis. It also stressed that maintaining proper storage conditions for the samples prior to testing falls under the responsibility of Sri Lankan health authorities.
The National Medicines Regulatory Authority (NMRA) ordered the immediate removal of four batches of the Ondansetron injection from both public and private hospitals on December 13. The drug, manufactured by Maan Pharmaceutical, was withdrawn following concerns over potential contamination.
Authorities have confirmed that the injection had been administered to two patients who later died. However, officials have emphasised that investigations are still ongoing to establish whether there is a direct link between the drug and the deaths.In its letter, Maan Pharmaceutical reiterated its call for prompt international testing of the affected batches and reaffirmed its commitment to meet all associated costs. The company also highlighted the need to verify that the samples were stored in line with required quality and safety standards before testing is carried out.
Leave your comments
Login to post a comment
Post comment as a guest